1 (Image 1)
Chemical structure of scopolamine, illustrating its molecular framework with characteristic atoms and bonding patterns.*
Scopolamine System
Product Images NDC 0591-2258
7 FDA label images from Actavis Pharma, Inc. · Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Scopolamine (NDC 0591-2258). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
1 (Image 2)
An instructional diagram showing the layers of a scopolamine transdermal system patch. The labeled layers include Backing Film on the top, Adhesive Matrix in the middle, and Release Liner on the bottom, illustrating the patch's structural components.*
1 (Image 3)
An instructional diagram showing parts of a scopolamine transdermal system labeled as 1 mg/3 days. The diagram identifies a clear disposable release liner, a metallic adhesive surface, and a tan backing film imprinted with "Scopolamine 1 mg/3 days."*
1 (Image 4)
Illustration showing how to cut open a package along a dashed line. The diagram includes an arrow pointing to the dashed line with a label instructing to cut the package open there, labeled as Figure 2.*
1 (Image 5)
An illustration showing a person peeling a clear, disposable release liner from a tan-colored transdermal system with a metallic adhesive surface. The image highlights the components of the scopolamine transdermal system. Figured labeled as Figure 3.*
1 (Image 6)
An illustration shows the placement of a tan-colored scopolamine transdermal system behind a person's ear on the side of the head. A line points to the patch, labeled as the imprinted transdermal system.*
1 (Image 7)
The image shows the packaging label for Scopolamine Transdermal System 1 mg/3 days by Actavis Pharma, Inc. The label features dosing information indicating delivery of approximately 1 mg over three days for motion sickness and postoperative nausea and vomiting prevention. The package contains 4 transdermal systems, with instructions, caution, storage details, and serialization coding area included. The Teva logo is displayed on a blue and gray background band.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
